Portfolio companies.
34,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals

216

currently held

Exits tracked

hand-checked

Sectors covered

across the portfolio

Countries covered

from every market

Latest activityLast event 2026-09-23

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Elaia PartnersadminCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway2 weeks ago

Elaia Partners2 weeks ago

CEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway

admin

Lauxera Capital PartnersadminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board1 month ago

Company	Sector	Geo	Investor	Entry	Hold	Status	Buyer	MOIC
Cisbio Bioassays Argos Fund VI	Biotech	France	Argos Wityu	2013	3yr	Exited 2016	Abenex	–
GenSight Biologics S.A. HealthCap VI	Biotech	France	HealthCap	2015	1yr	Exited 2016	–	–
Noxxon BioDiscovery 2	Biotech	France	Andera Partners	2007	9yr	Exited 2016	–	–
Tobira Therapeutics BioDiscovery 3	Biotech	France	Andera Partners	2009	7yr	Exited 2016	Allergan	–
Amoéba Evolem Start	Biotech	France	Evolem	2011	4yr	Exited 2015	–	–
Cerenis Therapeutics Holding SA HealthCap V	Biotech	France	HealthCap	2005	10yr	Exited 2015	–	–
Glycovaxin BioDiscovery 3	Biotech	France	Andera Partners	2009	6yr	Exited 2015	GSK	–
Vivoryon BioDiscovery 3	Biotech	France	Andera Partners	2009	5yr	Exited 2014	–	–
Cellectis Odyssee Venture Funds	Biotech	France	Odyssée Venture	2002	12yr	Exited 2014	–	–
DBV Sofinnova Capital VI	Biotech	France	Sofinnova Partners	2010	4yr	Exited 2014	–	–
GenKyoTex BioDiscovery 3	Biotech	France	Andera Partners	2011	3yr	Exited 2014	–	–
LIBRAGEN Galia Investissements I	Biotech	France	Galia Gestion	2004	7yr	Exited 2011	Induchem	–
Novexel Sofinnova Capital VI	Biotech	France	Sofinnova Partners	2006	4yr	Exited 2010	AstraZeneca	–
Innate Pharma Sofinnova Capital VI	Biotech	France	Sofinnova Partners	2000	6yr	Exited 2006	–	–
Genset Sofinnova Capital VI	Biotech	France	Sofinnova Partners	1989	13yr	Exited 2002	Serono	–
Bioptimus7 periods Felix Capital Fund IV	Biotech	France	Felix Capital	2024	2yr	Active	–	–
Aqemia5 periods Cathay Innovation Fund III	Biotech	France	Cathay Capital	2019	7yr	Active	–	–
Abivax4 periods BioDiscovery 6	Biotech	France	Andera Partners	2013	13yr	Active	–	–
Antabio4 periods FIP APL 2015	Biotech	France	iXO Private Equity	2017	9yr	Active	–	–
Augustine Therapeutics4 periods Jeito II	Biotech	France	Jeito Capital	2019	7yr	Active	–	–
Microphyt4 periods SOFILARO	Biotech	France	Sofilaro Gestion	2013	13yr	Active	–	–
Oncodesign4 periods Nov Sante Actions Non Cotees	Biotech	France	Eurazeo	2008	18yr	Active	–	–
Primaa4 periods Odyssee Venture Funds	Biotech	France	Odyssée Venture	2019	7yr	Active	–	–
Qubit Pharmaceuticals4 periods Omnes Real Tech 1	Biotech	France	Omnes Capital	2020	6yr	Active	–	–
SparingVision4 periods Ysios BioFund III	Biotech	France	Ysios Capital Partners	2019	7yr	Active	–	–
AM Pharma3 periods BioDiscovery 5	Biotech	France	Andera Partners	2011	15yr	Active	–	–
Biophta3 periods Elaia Digital Venture Fund V	Biotech	France	Lazard Elaia Capital	2024	2yr	Active	–	–
Cell-Easy3 periods IRDI Capital Croissance	Biotech	France	Irdi Capital-Investissement	2020	6yr	Active	–	–
Coave Therapeutics3 periods Novo Holdings Venture Investments	Biotech	France	Novo Holdings	2015	11yr	Active	–	–
Corteria Pharmaceuticals3 periods Jeito I	Biotech	France	Jeito Capital	2021	5yr	Active	–	–
Enterome3 periods Principia III - Health	Biotech	France	Principia SGR	2012	14yr	Active	–	–
Enyo Pharma3 periods BioDiscovery 5	Biotech	France	Andera Partners	2016	10yr	Active	–	–
Genoskin3 periods OCCIDEV IMPACTS	Biotech	France	OCCTE	2024	2yr	Active	–	–
Integra Therapeutics3 periods Columbus Life Sciences Fund III	Biotech	France	Columbus Venture Partners	2021	5yr	Active	–	–
Inventiva3 periods Claret European Growth Capital Fund IV	Biotech	France	Claret Capital Partners	2019	7yr	Active	–	–
Maat Pharma3 periods Health for Life Capital	Biotech	France	Seventure Partners	2016	10yr	Active	–	–
NMD Pharma3 periods Jeito I	Biotech	France	Jeito Capital	2016	10yr	Active	–	–
Owkin3 periods Otium Venture	Biotech	France	FRST Capital	2013	13yr	Active	–	–
SeqOne Genomics3 periods Mérieux Innovation 1	Biotech	France	Merieux Equity Partners	2019	7yr	Active	–	–
TreeFrog Therapeutics3 periods Galia Investissements IV	Biotech	France	Galia Gestion	2018	8yr	Active	–	–
Vivet Therapeutics3 periods Columbus Innvierte Life Science Fund I	Biotech	France	Columbus Venture Partners	2016	10yr	Active	–	–
Actithera2 periods Sofinnova Capital XI	Biotech	France	Sofinnova Partners	2025	1yr	Active	–	–
Alentis Therapeutics2 periods Novo Holdings Venture Investments	Biotech	France	Novo Holdings	2021	5yr	Active	–	–
Alveus Therapeutics2 periods Jeito II	Biotech	France	Jeito Capital	2026	0yr	Active	–	–
AlzProtect2 periods FIRA	Biotech	France	Finovam Gestion	2017	9yr	Active	–	–
baCta2 periods Daphni Blue	Biotech	France	Daphni	2024	2yr	Active	–	–
Basecamp Research2 periods Singular Ventures II	Biotech	France	Singular Capital Partners	2023	3yr	Active	–	–
Brenus Pharma2 periods UI Investissement	Biotech	France	UI Investissement	2024	2yr	Active	–	–
bYoRNA2 periods IRDI Capital Croissance	Biotech	France	Irdi Capital-Investissement	2025	1yr	Active	–	–
DNA Script2 periods Kurma Diagnostics II	Biotech	France	Eurazeo	2017	9yr	Active	–	–

Portfolio companies.34,000+ PE-backed.

Portfolio companies.
34,000+ PE-backed.